Phagocytosis of <span class='italic'>Streptococcus pneumoniae</span>

doi:10.1017/CBO9780511541513.005

5 - Phagocytosis of Streptococcus pneumoniae

Published online by Cambridge University Press: 07 August 2009

Dominic L. Jack ,

David H. Dockrell ,

Stephen B. Gordon and

Robert C. Read

Edited by

Joel D. Ernst and

Olle Stendahl

Show author details

Dominic L. Jack: Affiliation:
Professor of Medical Microbiology Linköping University
David H. Dockrell: Affiliation:
Division of Genomic Medicine University of Sheffield Medical School, Beech Hill Road
Robert C. Read: Affiliation:
Division of Genomic Medicine University of Sheffield Medical School
Joel D. Ernst: Affiliation:
New York University
Olle Stendahl: Affiliation:
Linköpings Universitet, Sweden

Book contents

Get access

Summary

INTRODUCTION

Streptococcus pneumoniae is a major cause of morbidity and mortality worldwide, and commonly colonizes the upper respiratory tract. In some colonized individuals the organism translocates to other tissues and causes life-threatening diseases including pneumonia, bacteremia, and meningitis. Rates of disease are especially high in the very young and old and in patients with predisposing conditions including HIV infection, cardiopulmonary or co-morbidities, renal diseases including nephrotic syndrome, and sickle cell disease and other causes of hyposplenia.

Approximately 5 million children under the age of 5 years die with a respiratory tract infection every year; the major causative pathogen in these cases is S. pneumoniae (Williams et al. 2002). Pneumococcal infection caused approximately 45,000 deaths in adults in the United States in 1998, about two years prior to the introduction of the 7-valent pneumococcal conjugate vaccine for infants (Robinson et al. 2001). Streptococcus pneumoniae also causes less serious but extremely common diseases such as otitis media, sinusitis and exacerbations of chronic obstructive pulmonary disease. It has been estimated that there are 7 million cases of otitis media in the United States every year (Stool & Field 1989).

OVERVIEW OF PATHOGENESIS

Nasopharyngeal carriage

The first step in the pathogenesis of pneumococcal disease is nasopharyngeal colonization, with individuals often carrying more than one serotype at a time. Asymptomatic nasopharyngeal carriage is established when surface components of the pneumococcus bind to nasal epithelium (Tuomanen & Masure 1997; Weiser et al., 1996).

Type: Chapter
Information: Phagocytosis of Bacteria and Bacterial Pathogenicity , pp. 135 - 180

DOI: https://doi.org/10.1017/CBO9780511541513.005 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Agostini, C., Sancetta, R., Cerutti, A., and Semenzato, G.. 1995. Alveolar macrophages as a cell source of cytokine hyperproduction in HIV-related interstitial lung disease. J Leukoc Biol 58(5): 495–500.CrossRef Google Scholar PubMed

Ali, F., Lee, M. E., Iannelli, F.et al. 2003. Streptococcus pneumoniae-associated human macrophage apoptosis after bacterial internalization via complement and Fcgamma receptors correlates with intracellular bacterial load. J Infect Dis 188: 1119–31CrossRef Google Scholar PubMed

Allen, R. C., Mills, E. L., McNitt, T. R., and Quie, P. G.. 1981. Role of myeloperoxidase and bacterial metabolism in chemiluminescence of granulocytes from patients with chronic granulomatous disease. J Infect Dis 144: 344–8CrossRef Google Scholar PubMed

Alonso de Velasco, E., A. F. Verheul, Verhoef, J., and H Snippe. 1995. Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol Rev 59: 591–603Google Scholar

Antony, V. B., Godbey, S. W., Hott, J. W., and Queener, S. F.. 1993. Alcohol-induced inhibition of alveolar macrophage oxidant release in vivo and in vitro. Alcohol Clin Exp Res 17(2): 389–93CrossRef Google Scholar PubMed

Arulanandam, B. P., Lynch, J. M., D. E. Briles, Hollingshead, S., and Metzger, D. W.. 2001. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection. Infect Immun 69(11): 6718–24CrossRef Google Scholar PubMed

Bals, R., Wang, X., Wu, Z.et al. 1998. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 102(5): 874–80CrossRef Google Scholar PubMed

Bergeron, Y., Ouellet, N., A. M. Deslauriers et al. 1998. Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice. Infect Immun 66(3): 912–22Google Scholar PubMed

Bergeron, Y., Ouellet, N., Simard, M., Olivier, M., and Bergeron, M. G.. 1999. Immunomodulation of pneumococcal pulmonary infection with N(G)-monomethyl-L-arginine. Antimicrob Agents Chemother 43: 2283–90Google Scholar

Blumenthal, R. L., D. E. Campbell, P. Hwang et al. 2001. Human alveolar macrophages induce functional inactivation in antigen-specific CD4 T cells. J Allergy Clin Immunol 107(2): 258–64CrossRef Google Scholar PubMed

Bottcher, T., Gerber, J., Wellmer, A.et al. 2000. Rifampin reduces production of reactive oxygen species of cerebrospinal fluid phagocytes and hippocampal neuronal apoptosis in experimental Streptococcus pneumoniae meningitis. J Infect Dis 181: 2095–8CrossRef Google Scholar PubMed

Botto, M. 2000. C3. In The Complement Factsbook, 1st edn, Morley, B. J. & Walport, M. J., eds, pp. 88–94. London: Academic Press.Google Scholar

Boyton, R. J., and Openshaw, P. J.. 2002. Pulmonary defences to acute respiratory infection. Br Med Bull 61: 1–12CrossRef Google Scholar PubMed

Braun, J. S., Novak, R., Gao, G., Murray, P. J., and Shenep, J. L.. 1999. Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages. Infect Immun 67: 3750–6Google Scholar PubMed

Briles, D. E., Nahm, M., Schroer, K.et al. 1981. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J Exp Med 153: 694–705CrossRef Google Scholar PubMed

Briles, D. E., Tart, R. C., Swiatlo, E.et al. 1998. Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clin Microbiol Rev 11: 645–57Google Scholar

Brown, E. J., Hosea, S. W., and Frank, M. M.. 1981. The role of the spleen in experimental pneumococcal bacteremia. J Clin Invest 67(4): 975–82CrossRef Google Scholar PubMed

Brown, E. J., Hosea, S. W., and Frank, M. M.. 1983a. The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the bloodstream. Rev Infect Dis 5 (Suppl 4): S797–S805CrossRef Google Scholar

Brown, E. J., Joiner, K. A., Cole, R. M., and Berger, M. 1983b. Localisation of complement component 3 on Streptococcus pneumoniae; anti-capsular antibody causes complement deposition on the pneumococcal capsule. Infect Immun 39(1): 403–9Google Scholar

Brown, J. S., Hussell, T., S. M. Gilliand et al. 2002. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci USA 99: 16969–74CrossRef Google Scholar PubMed

Chelen, C. J., Fang, Y., G. J. Freeman et al. 1995. Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules. J Clin Invest 95(3): 1415–21CrossRef Google Scholar PubMed

Chen, G. H., Reddy, R. C., M. W. Newstead et al. 2000. Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense. J Immunol 165(11): 6496–503CrossRef Google Scholar PubMed

Clark, R. A. 1986. Oxidative inactivation of pneumolysin by the myeloperoxidase system and stimulated human neutrophils. J Immunol 136: 4617–22Google Scholar PubMed

Clatworthy, M. R., and Smith, K. G.. 2004. Fc{gamma}RIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis. J Exp Med 199(5): 717–23CrossRef Google Scholar

Coakley, R. J., Taggart, C., McElvaney, N. G., and S. J. O'Neill. 2002. Cytosolic pH and the inflammatory microenvironment modulate cell death in human neutrophils after phagocytosis. Blood 100: 3383–91CrossRef Google Scholar PubMed

Cockeran, R., Anderson, R., and Feldman, C.. 2002a. The role of pneumolysin in the pathogenesis of Streptococcus pneumoniae infection. Curr Opin Infect Dis 15(3): 235–9CrossRef Google Scholar

Cockeran, R., Durandt, C., Feldman, C., Mitchell, T. J., and Anderson, R.. 2002b. Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro. J Infect Dis 186: 562–565CrossRef Google Scholar

Colino, J., Shen, Y., and Snapper, C. M.. 2002. Dendritic cells pulsed with intact Streptococcus pneumoniae elicit both protein- and polysaccharide-specific immunoglobulin isotype responses in vivo through distinct mechanisms. J Exp Med 195(1): 1–13CrossRef Google Scholar PubMed

Coonrod, J. D. 1986. The role of extracellular bactericidal factors in pulmonary host defense. Semin Respir Infect 1: 118–29Google Scholar PubMed

Coonrod, J. D. 1989. Role of leukocytes in lung defenses. Respiration 55 (Suppl 1): 9–13CrossRef Google Scholar PubMed

Coonrod, J. D., and Yoneda, K.. 1981. Complement and opsonins in alveolar secretions and serum of rats with pneumonia due to Streptococcus pneumoniae. Rev Infect Dis 3(2): 310–22CrossRef Google Scholar PubMed

Coonrod, J. D., Varble, R., and Jarrells, M. C.. 1990. Species variation in the mechanism of killing of inhaled pneumococci. J Lab Clin Med 116(3): 354–62Google Scholar PubMed

Crouch, E., and Wright, J. R.. 2001. Surfactant proteins A and D and pulmonary host defense. Rev Physiol 63: 521–54CrossRef Google Scholar

Cundell, D. R., Gerard, N. P., Gerard, C., Idanpaan, H. I., and Tuomanen, E. I.. 1995. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 377(6548): 435–8CrossRef Google Scholar PubMed

Dave, S., A. Brooks-Walter, Pangburn, M. K., and McDaniel, L. S.. 2001. PspC, a pneumococcal surface protein, binds human factor H. Infect Immun 69: 3435–7CrossRef Google Scholar PubMed

Dave, S., Carmicle, S., Hammerschmidt, S., Pangburn, M. K., and McDaniel, L. S.. 2004. Dual roles of PspC, a surface protein of Streptococcus pneumoniae, in binding human secretory IgA and factor H. J Immunol 173: 471–4CrossRef Google Scholar PubMed

Delclaux, C., S. Rezaiguia-Delclaux, C. Delacourt et al. 1997. Alveolar neutrophils in endotoxin-induced and bacteria-induced acute lung injury in rats. Am J Physiol 273: L104–2Google Scholar PubMed

Dempsey, P. W., Allison, M. E., Akkaraju, S., Goodnow, C. C., and Fearon, D. T.. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271: 348–50CrossRef Google Scholar PubMed

Dintilhac, A., Alloing, G., Granadel, C., and Claverys, J. P.. 1997. Competence and virulence of Streptococcus pneumoniae: Adc and PsaA mutants exhibit a requirement for zinc and manganese resulting from an activation of putative ABC metal permeases. Molec Microbiol 25: 727–39CrossRef Google Scholar

Dockrell, D. H. 2001. Apoptotic cell death in the pathogenesis of infectious diseases. J Infect 42: 227–34CrossRef Google Scholar PubMed

Dockrell, D. H., Lee, M., Lynch, D. H., and Read, R. C.. 2001. Immune-mediated phagocytosis and killing of Streptococcus pneumoniae are associated with direct and bystander macrophage apoptosis. J Infect Dis 184: 713–22CrossRef Google Scholar PubMed

Dockrell, D. H., Marriott, H. M., L. R. Prince et al. 2003. Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infection. J Immunol 171(10): 5380–8CrossRef Google Scholar

Doerschuk, C. M. 2001. Mechanisms of leukocyte sequestration in inflamed lungs. Microcirculation 8: 71–8CrossRef Google Scholar PubMed

Emmerik, L. C. v., Kuijper, E. J., C. A. Fijen, Dankert, J., and Thiel, S.. 1994. Binding of mannan-binding protein to various bacterial pathogens of meningitis. Clin Exp Immunol 97: 411–6CrossRef Google Scholar PubMed

Esposito, A. L. 1984. Aspirin impairs antibacterial mechanisms in experimental pneumococcal pneumonia. Am Rev Respir Dis 130(5): 857–62Google Scholar PubMed

Esposito, A. L. 1985. Digoxin disrupts the inflammatory response in experimental pneumococcal pneumonia. J Infect Dis 152(1): 14–23CrossRef Google Scholar PubMed

Ettensohn, D. B., and N. J. Roberts, Jr. 1983. Human alveolar macrophage support of lymphocyte responses to mitogens and antigens. Analysis and comparison with autologous peripheral-blood-derived monocytes and macrophages. Am Rev Respir Dis 128(3): 516–22CrossRef Google Scholar PubMed

Fang, F. C. 2004. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2: 820–32CrossRef Google Scholar PubMed

Gaboriaud, C., Thielens, N. M., L. A. Gregory et al. 2004. Structure and activation of the C1 complex of complement: unraveling the puzzle. Trends Immunol 25: 368–73CrossRef Google Scholar PubMed

Gant, V., Cluzel, M., Shakoor, Z.et al. 1992. Alveolar macrophage accessory cell function in bronchial asthma. Am Rev Respir Dis 146(4): 900–4CrossRef Google Scholar PubMed

Gardner, S. E., Anderson, D. C., B. J. Webb et al. 1982. Evaluation of Streptococcus pneumoniae type XIV opsonins by phagocytosis-associated chemiluminescence and a bactericidal assay. Infect Immun 35(3): 800–8Google Scholar

Garg, M., Kaplan, A. M., and Bondada, S.. 1994. Cellular basis of differential responsiveness of lymph nodes and spleen to 23-valent Pnu-Imune vaccine. J Immunol 152(4): 1589–96Google Scholar PubMed

Gentry, M. J., Snitily, M. U., and Preheim, L. C.. 1995. Phagocytosis of Streptococcus pneumoniae measured in vitro and in vivo in a rat model of carbon tetrachloride-induced liver cirrhosis. J Infect Dis 171(2): 350–5CrossRef Google Scholar

Goldblatt, D. 2000. Conjugate vaccines. Clin Exp Immunol 119: 1–3CrossRef Google Scholar PubMed

Gordon, S. B., and Read, R. C.. 2002. Macrophage defences against respiratory tract infections. Br Med Bull 61: 45–61CrossRef Google Scholar PubMed

Gordon, S. B., Irving, G. R., R. A. Lawson, Lee, M. E., and Read, R. C.. 2000. Intracellular trafficking and killing of Streptococcus pneumoniae by human alveolar macrophages are influenced by opsonins. Infect Immun 68(4): 2286–93CrossRef Google Scholar PubMed

Gordon, S. B., Molyneux, M. E., M. J. Boeree et al. 2001. Opsonic phagocytosis of Streptococcus pneumoniae by alveolar macrophages is not impaired in human immunodeficiency virus-infected Malawian adults. J Infect Dis 184(10): 1345–9CrossRef Google Scholar

Gordon, S. B., Miller, D. E., R. B. Day et al. 2003. Pulmonary immunoglobulin responses to Streptococcus pneumoniae are altered but not reduced in Human Immunodeficiency Virus-infected Malawian adults. J Infect Dis 188(5): 666–70CrossRef Google Scholar

Gordon, S. B., Jarman, E. R., Kanyanda, S.et al. 2005. Reduced interleukin-8 response to Streptococcus pneumoniae by alveolar macrophages from adults with HIV/AIDS. AIDS 19(11): 1197–200CrossRef Google Scholar PubMed

Green, G. M. 1985. Mechanisms of tobacco smoke toxicity on pulmonary macrophage cells. Eur J Respir Dis (Suppl) 139: 82–5Google Scholar PubMed

Greenberg, J. W., Fischer, G. W., and Joiner, K. A.. 1996. Influence of lipoteichoic acid structure on recognition by the macrophage scavenger receptor. Infect Immun 64(8): 3318–25Google Scholar PubMed

Greenberg, S. S., Zhao, X., Hua, L.et al. 1999. Ethanol inhibits lung clearance of Pseudomonas aeruginosa by a neutrophil and nitric oxide-dependent mechanism, in vivo. Alcohol Clin Exp Res 23(4): 735–44CrossRef Google Scholar PubMed

Guo, R. F., and Ward, P. A.. 2002, Mediators and regulation of neutrophil accumulation in inflammatory responses in lung: insights from the IgG immune complex model. Free Radical Biol Med 33: 303–10CrossRef Google Scholar PubMed

Hammerschmidt, S., Talay, S. R., Brandtzaeg, P., and Chatwall, G. S.. 1997. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Molec Microbiol 35: 1113–24CrossRef Google Scholar

Hammerschmidt, S., Bethe, G., Remane, P. H., and Chatwall, G. S.. 1999. Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae. Infect Immun 67: 1683–7Google Scholar PubMed

Harms, G., Hardonk, M. J., and Timens, W.. 1996. In vitro complement-dependent binding and in vivo kinetics of pneumococcal polysaccharide TI-2 antigens in the rat spleen marginal zone and follicle. Infect Immun 64(10): 4220–5Google Scholar PubMed

Hartshorn, K. L., Crouch, E., M. R. White et al. 1998. Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria. Am J Physiol 274: L958–69Google Scholar

Haslett, C. 1999. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Respir Crit Care Med 160: S5–11CrossRef Google Scholar PubMed

Haynes, B. F., Telen, M. J., Hale, L. P., and Denning, S. N.. 1989. CD44 – a molecule involved in leucocyte adherence and T cell activation. Immunol Today 10: 423–8CrossRef Google Scholar PubMed

Hebert, J. C., and M. O'Reilly. 1996. Granulocyte-macrophage colony-stimulating factor (GM-CSF) enhances pulmonary defenses against pneumococcal infections after splenectomy. J Trauma 41(4): 663–6CrossRef Google Scholar PubMed

Hebert, J. C., M. O'Reilly, K. Yuenger et al. 1994. Augmentation of alveolar macrophage phagocytic activity by granulocyte colony stimulating factor and interleukin-1: influence of splenectomy. J Trauma 37: 909–12CrossRef Google Scholar PubMed

Henneke, P., Takeuchi, O., Malley, R.et al. 2002. Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways. J Immunol 169: 3970–7CrossRef Google Scholar PubMed

Hetts, S. W. 1998. To die or not to die: an overview of apoptosis and its role in disease. JAMA 279: 300–7CrossRef Google Scholar PubMed

Hirschmann, J. V., and Lipsky, B. A.. 1994. The pneumococcal vaccine after 15 years of use. Arch Intern Med 154: 373–7CrossRef Google Scholar PubMed

Hof, D. G., Repine, J. E., Peterson, P. K., and Hoidal, J. R.. 1980. Phagocytosis by human alveolar macrophages and neutrophils: qualitative differences in the opsonic requirements for uptake of Staphylococcus aureus and Streptococcus pneumoniae in vitro. Am Rev Respir Dis 121: 65–71Google Scholar PubMed

Hof, D. G., Repine, J. E., Giebink, G. S., and Hoidal, J. R.. 1981. Production of opsonins that facilitate phagocytosis of Streptococcus pneumoniae by human alveolar macrophages or neutrophils after vaccination with pneumococcal polysaccharide. Am Rev Respir Dis 124: 193–5Google Scholar PubMed

Hogg, N. 1992. Roll, roll, roll your leukocyte gently down the vein. Immunol Today 13: 113–5CrossRef Google Scholar PubMed

Hoidal, J. R., Schmeling, D., and Peterson, P. K.. 1981. Phagocytosis, bacterial killing, and metabolism by purified human lung phagocytes. J Infect Dis 144(1): 61–71CrossRef Google Scholar PubMed

Holmskov, U., Thiel, S., and Jensenius, J. C.. 2003. Collectins and ficolins: Humoral lectins of the innate immune defense. A Rev Immunol 21: 547–78CrossRef Google Scholar PubMed

Hosea, S. W., Brown, E. J., and Frank, M. M.. 1980. The critical role of complement in experimental pneumococcal sepsis. J Infect Dis 142: 903–9CrossRef Google Scholar PubMed

Hosea, S. W., Brown, E. J., Hamburger, M. I., and Frank, M. M.. 1981a. Opsonic requirements for intravascular clearance after splenectomy. New Engl J Med 304: 245–50CrossRef Google Scholar

Hosea, S. W., C. G. Burch, E. J. Brow, Berg, R. A., and Frank, M. M.. 1981b. Impaired immune response of splenectomised patients to polyvalent pneumococcal vaccine. Lancet 1(8224): 804–7CrossRef Google Scholar

Hostetter, M. K. 1986. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production. J Infect Dis 153: 682–93CrossRef Google Scholar PubMed

Hostetter, M. K. 1999. Opsonic and nonopsonic interactions of C3 with Streptococcus pneumoniae. Microb Drug Resist Mech Epidem Dis 5: 85–9CrossRef Google Scholar PubMed

Huber, G. L., Sornberger, G. C., Mahajan, V., Cutting, M. E., and McCarthy, C. R.. 1997. Impairment of alveolar macrophage bactericidal function by cigar smoke. Bull Eur Physiopathol Respir 13(4): 513–21Google Scholar

Hunninghake, G. W., Gallin, J. I., and Fauci, A. S.. 1978. Immunologic reactivity of the lung: the in vivo and in vitro generation of a neutrophil chemotactic factor by alveolar macrophages. Am Rev Respir Dis 117(1): 15–23Google Scholar

Ieong, M. H., Reardon, C. C., Levitz, S. M., and Kornfeld, H.. 2000. Human immunodeficiency virus type 1 infection of alveolar macrophages impairs their innate fungicidal activity. Am J Resp Crit Care Med 162(3 Pt 1): 966–70CrossRef Google Scholar PubMed

Jack, D. L., Klein, N. J., and Turner, M. W.. 2001. Mannose-binding lectin: targetting the microbial world for complement attack and opsonophagocytosis. Immunol Rev 180: 86–99CrossRef Google Scholar

Janoff, E. N., Fasching, C., Orenstein, J. M.et al. 1999. Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes. J Clin Invest 104: 1139–47CrossRef Google Scholar PubMed

Jarva, H., Janulczyk, R., Hellwage, J.et al. 2002. Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8–11 of factor H. J Immunol 168: 1886–94CrossRef Google Scholar PubMed

Jedrzejas, M. J. 2001. Pneumococcal virulence factors: structure and function. Microbiol Molec Biol Rev 65: 187–207CrossRef Google Scholar PubMed

Jeffery, P. K. 1987. The origins of secretions in the lower respiratory tract. Eur J Respir Dis (Suppl) 153: 34–42Google Scholar PubMed

Johnson, J. D., Hand, W. L., King, N. L., and Hughes, C. G.. 1975. Activation of alveolar macrophages after lower respiratory tract infection. J Immunol 115: 80–4Google Scholar PubMed

Johnson, S., Opstad, N. L., J. M. Jr. Douglas, and Janoff, E. N.. 1996. Prolonged and preferential production of polymeric immunoglobulin A in response to Streptococcus pneumoniae capsular polysaccharides. Infect Immun 64: 4339–44Google Scholar PubMed

Jonsson, S., Musher, D. M., Chapman, A., Goree, A., and Lawrence, E. C.. 1985. Phagocytosis and killing of common bacterial pathogens of the lung by human alveolar macrophages. J Infect Dis 152(1): 4–13CrossRef Google Scholar

Jounblat, R., Kadioglu, A., Mitchell, T. J., and Andrew, P. W.. 2003. Pneumococcal behavior and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin (vol 71: pg 1813, 2003). Infect Immun 71: 7239CrossRef Google Scholar

Jounblat, R., Kadioglu, A., Iannelli, F.et al. 2004. Binding and agglutination of Streptococcus pneumoniae by human surfactant protein D (SP-D) vary between strains but, SP-D fails to enhance killing by neutrophils. Infect Immun 72: 709–16CrossRef Google Scholar PubMed

Kadioglu, A., Gingles, N. A., Grattan, K.et al. 2000. Host cellular immune response to pneumococcal lung infection in mice. Infect Immun 68: 492–501CrossRef Google Scholar PubMed

Kadioglu, A., Coward, W., M. J. Colston, C. R. A. Hewitt, and Andrew, P. W.. 2004. CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection. Infect Immun 72(5): 2689–97CrossRef Google Scholar PubMed

Kang, Y.-S., J. Y. Kim, S. A. Bruening et al. 2004. The C-type lectin SIGN-RI mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen. Proc Natl Acad Sci USA 101(1): 215–20CrossRef Google Scholar

Karlsson, M. C. I., Guinamard, R., Bolland, S.et al. 2003. Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J Exp Med 198(2): 333–40CrossRef Google Scholar PubMed

Kerr, A. R., Wei, X. Q., Andrew, P. W., and Mitchell, T. J.. 2004. Nitric oxide exerts distinct effects in local and systemic infections with Streptococcus pneumoniae. Microb Pathog 36: 303–310CrossRef Google Scholar PubMed

Kiluchi, R., Watabe, N., Konno, T., Mishina, N., Sekizawa, K., and Sasaki, H.. 1994. High incidence of silent aspiration in elderly individuals with community acquired pneumonia. Am J Resp Crit Care Med 150: 251–3Google Scholar

Kim, J. O., and Weiser, J. N.. 1998. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J Infect Dis 177(2): 368–77CrossRef Google Scholar PubMed

Klein, N. J., Ison, C. A., Peakman, M.et al. 1996. The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis. J Infect Dis 173: 172–9CrossRef Google Scholar PubMed

Knapp, S., Leemans, J. C., Florquin, S.et al. 2003. Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. Am J Respir Crit Care Med 167(2): 171–9CrossRef Google Scholar PubMed

Koch, C. C., Esteban, D. J., A. C. Chin et al. 2000. Apoptosis, oxidative metabolism and interleukin-8 production in human neutrophils exposed to azithromycin: effects of Streptococcus pneumoniae. J Antimicrob Chemother 46: 19–26CrossRef Google Scholar PubMed

Koziel, H., Li, X., M. Y. Armstrong, Richards, F. F., and Rose, R. M.. 2000. Alveolar macrophages from human immunodeficiency virus-infected persons demonstrate impaired oxidative burst response to Pneumocystis carinii in vitro. Am J Respir Cell Mol Biol 23(4): 452–9CrossRef Google Scholar PubMed

Kragsbjerg, P., and Fredlund, H.. 2001. The effects of live Streptococcus pneumoniae and tumor necrosis factor-α on neutrophil oxidative burst and β2-integrin expression. Clin Microbiol Infect 7: 125–9CrossRef Google Scholar

Kronborg, G., and Garred, P.. 2002. Mannose-binding lectin genotype as a risk factor for invasive pneumococcal infection. Lancet 360: 1176CrossRef Google Scholar PubMed

Kruetzmann, S., Rosado, M. M., Weber, H.et al. 2003. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 197(7): 939–45CrossRef Google Scholar

Kunkel, E. J., and Butcher, E. C.. 2003. Plasma-cell homing. Nat Rev Immunol 3(10): 822–829CrossRef Google Scholar PubMed

Kuronuma, K., Sano, H., Kato, K.et al. 2004. Pulmonary surfactant protein A augments the phagocytosis of Streptococcus pneumoniae by alveolar macrophages through a casein kinase 2-dependent increase of cell surface localization of scavenger receptor A. J Biol Chem 279: 21421–30CrossRef Google Scholar PubMed

Lambrecht, B. N., Prins, J. B., and Hoogsteden, H. C.. 2001. Lung dendritic cells and host immunity to infection. Eur Respir J 18(4): 692–704Google Scholar PubMed

Lammas, D. A., Stober, C., C. J. Harvey et al. 1997. ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity 7: 433–44CrossRef Google Scholar PubMed

Lee, W. L., and Downey, G. P.. 2001. Neutrophil activation and acute lung injury. Curr Opin Crit Care 7: 1–7CrossRef Google Scholar PubMed

Lee, H. Y., Andalibi, A., Webster, P.et al. 2004. Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae. BMC Infect Dis 4: 12CrossRef Google Scholar PubMed

Leusen, J. H. W., Verhoeven, A. J., and Roos, D.. 1996. Interactions between the components of the human NADPH oxidase: A review about the intrigues in the phox family. Front Biosci 1: d72–90Google Scholar PubMed

Li-Korotky, H. S., J. D. Swarts, Hebda, P. A., and Doyle, W. J.. 2004. Cathepsin gene expression profile in rat acute pneumococcal otitis media. Laryngoscope 114: 1032–6CrossRef Google Scholar PubMed

Liu, H., Perlman, H., Pagliari, L. J., and Pope, R. M.. 2001. Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages. Role of Mcl-1, independent of nuclear factor (NF)-kappaB, Bad, or caspase activation. J Exp Med 194: 113–26CrossRef Google Scholar PubMed

Lloyd-Evans, N., T. J. O'Dempsey, I. Baldeh et al. 1996. Nasopharyngeal carriage of pneumococci in Gambian children and in their families. Pediatr Infect Dis J 15(10): 866–71CrossRef Google Scholar PubMed

Lohmann-Matthes, M. L., Steinmuller, C., and G. Franke-Ullmann. 1994. Pulmonary macrophages. Eur Respir J 7(9): 1678–89Google Scholar PubMed

Lopez, R., and Garcia, E.. 2004. Recent trends in the molecular microbiology of pneumococcal capsules, lytic enzymes and bacteriophage. FEMS Microbiol Rev 28: 553–80CrossRef Google Scholar PubMed

Lucas, M., Stuart, L. M., Savill, J., and A. Lacy-Hulbert. 2003. Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion. J Immunol 171: 2610–15CrossRef Google Scholar PubMed

Madsen, J., Kliem, A., I. Torn⊘e et al. 2000. Localization of lung surfactant protein D on mucosal surfaces in human tissues. J Immunol 164: 5866–70CrossRef Google Scholar PubMed

Marriott, H. M., Ali, F., R. C. Read et al. 2004. Nitric oxide levels regulate macrophage commitment to apoptosis or necrosis during pneumococcal infection. FASEB J 18: 1126–8CrossRef Google Scholar PubMed

McCool, T. L., Cate, T. R., Moy, G., and Weiser, J. N.. 2002. The immune response to pneumococcal proteins during experimental human carriage. J Exp Med 195: 359–65CrossRef Google Scholar PubMed

McCool, T. L., Cate, T. R., E. I. Tuomanen et al. 2003. Serum immunoglobulin G response to candidate vaccine antigens during experimental pneumococcal colonisation. Infection and Immunity 71: 5724–32CrossRef Google Scholar

McNeely, T. B., and Coonrod, J. D.. 1993. Comparison of the opsonic activity of human surfactant protein A for Staphylococcus aureus and Streptococcus pneumoniae with rabbit and human macrophages. J Infect Dis 167(1): 91–7CrossRef Google Scholar PubMed

Meli, D. N., Christen, S., and Leib, S. L.. 2003. Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway. J Infect Dis 187: 1411–5CrossRef Google Scholar PubMed

Mitchell, T. J. 2000. Virulence factors in the pathogenesis of disease caused by Streptococcus pneumoniae. Research Microbiol 151: 413–19CrossRef Google Scholar PubMed

Mizgerd, J.P, Kubo, H., G. J. Kutkosk et al. 1997. Neutrophil emigration in the skin, lungs, and peritoneum: different requirements for CD11/CD18 revealed by CD18-deficient mice. J Exp Med 186(8): 1357–64CrossRef Google Scholar PubMed

Mold, C., Edwards, K. M., and Gewurz, H.. 1982. Effect of C-reactive protein on the complement-mediated stimulated of human neutrophils by Streptococcus pneumoniae serotypes 3 and 6. Infect Immun 37: 987–92Google Scholar PubMed

Mold, C., B. Rodic-Polic, B., and T. W. Du Clos. 2002. Protection from Streptococcus pneumoniae Infection by C-reactive protein and natural antibody requires complement but not Fc{gamma} receptors. J Immunol 168: 6375–81CrossRef Google Scholar

Monier, R. M., Orman, K. L., Meals, E. A., and English, B. K.. 2002. Differential effects of p38- and extracellular signal-regulated kinase mitogen-activated protein kinase inhibitors on inducible nitric oxide synthase and tumor necrosis factor production in murine macrophages stimulated with Streptococcus pneumoniae. J Infect Dis 185: 921–6CrossRef Google Scholar PubMed

Moore, L. J., Pridmore, A. C., Dower, S. K., and Read, R. C.. 2003. Penicillin enhances the Toll-like Receptor 2-mediated proinflammatory activity of Streptococcus pneumoniae. J Infect Dis 188: 1040–8CrossRef Google Scholar PubMed

Muller, Q. J., Pfeifer, S., Mannel, D., Strausz, J., and Ferlinz, R.. 1992. Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. Am Rev Respir Dis 145(1): 187–92CrossRef Google Scholar

Murdoch, C., Read, R. C., Zhang, Q., and Finn, A.. 2002. Choline-binding protein A of Streptococcus pneumoniae elicits chemokine production and expression of intercellular adhesion molecule 1 (CD54) by human alveolar epithelial cells. J Infect Dis 186(9): 1253–60CrossRef Google Scholar PubMed

Musher, D. M., Watson, D. A., and Baughn, R. E.. 1990. Does naturally-acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infection. J Infect Dis 161: 736–40CrossRef Google Scholar PubMed

Musher, D. M., Groover, J. E., J. M. Roland et al. 1993. Antibody to capsular polysaccharides of Streptococcus pneumoniae in adults: prevalence, persistence, relation to carriage and resistance to infection. Clin Infect Dis 17: 66–73CrossRef Google Scholar

Musher, D. M., Groover, J. E., M. R. Reichler et al. 1997. Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization. Clin Infect Dis 24(3): 441–6CrossRef Google Scholar PubMed

Neth, O., Jack, D. L., A. W. Dodds et al. 2000. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 68: 688–93CrossRef Google Scholar PubMed

Nguyen, B. Y., Peterson, P. K., H. A. Verbrugh, Quie, P. G., and Hoidal, J. R.. 1982. Differences in phagocytosis and killing by alveolar macrophages from humans, rabbits, rats, and hamsters. Infect Immun 36(2): 504–9Google Scholar PubMed

Nicod, L. P., Cochand, L., and Dreher, D.. 2000. Antigen presentation in the lung: dendritic cells and macrophages. Sarcoidosis Vasc Diffuse Lung Dis 17(3): 246–55Google Scholar PubMed

Nielsen, B. W., N. Mukaida, and K. Matsushima. 1994. Macrophages as producers of chemotactic proinflammatory cytokines. In Macrophage-Pathogen Interactions, 1st edn. Zwilling, B. S. & Eisenstein, T. K., eds, pp. 131–42. New York: Marcel Dekker.Google Scholar

Nuorti, J. P., Butler, J. C., M. M. Farley et al. 2000. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med 342(10): 681–9CrossRef Google Scholar PubMed

Omidvari, K., Casey, R., Nelson, S., Olariu, R., and Shellito, J. E.. 1998. Alveolar macrophage release of tumor necrosis factor-alpha in chronic alcoholics without liver disease. Alcohol Clin Exp Res 22(3): 567–72CrossRef Google Scholar PubMed

Orman, K. L., Shenep, J. L., and English, B. K.. 1998. Pneumococci stimulate the production of the inducible nitric oxide synthase and nitric oxide by murine macrophages. J Infect Dis 178: 1649–57CrossRef Google Scholar PubMed

Out, T. A., Wang, S. Z., Rudolph, K., and Bice, D. E.. 2002. Local T-cell activation after segmental allergen challenge in the lungs of allergic dogs. Immunology 105(4): 499–508CrossRef Google Scholar PubMed

Paton, J. C., B. Rowan-Kelly, and Ferrante, A.. 1984. Activation of human complement by the pneumococcal toxin pneumolysin. Infect Immun 43: 1085–7Google Scholar PubMed

Paton, J. C., Andrew, P. W., Boulnois, G. J., and Medshaw, T. J.. 1993. Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins. A Rev Microbiol 47: 89–115CrossRef Google Scholar PubMed

Perry, F. E., Elson, C. J., Greenham, L. W., and Catterall, J. R.. 1993. Interference with the oxidative response of neutrophils by Streptococcus pneumoniae. Thorax 48: 364–9CrossRef Google Scholar PubMed

Peset Llopis, M. J., Harms, G., Hardonk, M. J., and Timens, W.. 1996. Human immune response to pneumococcal polysaccharides: complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells. J Allergy Clin Immunol 97(4): 1015–24CrossRef Google Scholar

Pruul, H., Kriek, G., and McDonald, P. J.. 1988. Enoxacin-induced modification of the susceptibility of bacteria to phagocytic killing. J Antimicrob Chemother 21(Suppl B): 19–27CrossRef Google Scholar PubMed

Ramirez, M. C., and Sigal, L. J.. 2002. Macrophages and dendritic cells use the cytosolic pathway to rapidly cross-present antigen from live, vaccinia-infected cells. J Immunol 169(12): 6733–42CrossRef Google Scholar PubMed

Reeves, E. P., Lu, H., H. L. Jacobs et al. 2002. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 416: 291–7CrossRef Google Scholar PubMed

Ring, A., Weiser, J. N., and Tuomanen, E. I.. 1998. Pneumococcal trafficking across the blood-brain barrier. J Clin Invest 102(2): 347–60CrossRef Google Scholar PubMed

Robinson, K. A., Baughman, W., Rothrock, H.et al. 2001. Epidemiology of invasive Streptococcus pneumoniae infections in the United States 1995–1998. Opportunities for prevention in the conjugate vaccine era. JAMA 285: 1729–35CrossRef Google Scholar PubMed

Rogers, P. D., Thornton, J., K. S. Barker et al. 2003. Pneumolysin-dependent and -independent gene expression identified by cDNA microarray analysis of THP-1 human mononuclear cells stimulated by Streptococcus pneumoniae. Infect Immun 71: 2087–94CrossRef Google Scholar PubMed

Roos, A., Bouwman, L. H., D. J. Gijlswijk-Janssen et al. 2001. Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol 167: 2861–8CrossRef Google Scholar PubMed

Roy, S., Knox, K., Segal, S.et al. 2002. MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet 359: 1569–73CrossRef Google Scholar PubMed

Rubins, J. B. 2003. Alveolar macrophages: wielding the double-edged sword of inflammation. Am J Respir Crit Care Med 167(2): 103–4CrossRef Google Scholar PubMed

Rubins, J. B., and Janoff, E. N.. 1998. Pneumolysin: A multifunctional pneumococcal virulence factor. J Lab Clin Med 131: 21–7CrossRef Google Scholar PubMed

Ruff, R. L., and Secrist, D.. 1984. Inhibitors of prostaglandin synthesis or cathepsin B prevent muscle wasting due to sepsis in the rat. J Clin Invest 73: 1483–6CrossRef Google Scholar PubMed

Sanders, L. A., J. G. van-de-Winkel, G. T. Rijkers et al. 1994. Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis 170: 854–61CrossRef Google Scholar PubMed

Schaper, M., Leib, S. L., D. N. Meli et al. 2003. Differential effect of p47phox and gp91phox deficiency on the course of pneumococcal meningitis. Infect Immun 71: 4087–92CrossRef Google Scholar PubMed

Scott, J. A., Hall, A. J., Dagan, R.et al. 1996. Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, geography in 7,000 episodes of invasive disease. Clin Infect Dis 22: 973–81CrossRef Google Scholar PubMed

Shasby, D. M., Vanbenthuysen, K. M., R. M. Tate et al. 1982. Granulocytes mediate acute edematous lung injury in rabbits and in isolated rabbit lungs perfused with phorbol myristate acetate: role of oxygen radicals. Am Rev Respir Dis 125: 443–7Google Scholar PubMed

Shaw, D. R., and Griffin, F. M. J.. 1981. Phagocytosis requires repeated triggering of macrophage phagocytic receptors during particle ingestion. Nature 289: 409–11CrossRef Google Scholar PubMed

Shi, L., Takahashi, K., Dundee, J.et al. 2004. Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med 199: 1379–90CrossRef Google Scholar PubMed

Sibille, Y., and Reynolds, H. Y.. 1990. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 141: 471–501CrossRef Google Scholar PubMed

Sim, R. B., Twose, T. M., Paterson, D. S., and Sim, E.. 1981. The covalent binding reaction of complement component C3. Biochem J 193: 115–27CrossRef Google Scholar PubMed

Simell, B., Kilpi, T. M., and Kayhty, H.. 2002. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children. J Infect Dis 186(8): 1106–14CrossRef Google Scholar PubMed

Simpson, S. Q., Modi, H. N., R. A. Balk, Bone, R. C., and Casey, L. C.. 1991. Reduced alveolar macrophage production of tumor necrosis factor during sepsis in mice and men. Crit Care Med 19(8): 1060–6CrossRef Google Scholar PubMed

Simpson, S. Q., Singh, R., and Bice, D. E.. 1994. Heat-killed pneumococci and pneumococcal capsular polysaccharides stimulate tumor necrosis factor-alpha production by murine macrophages. Am J Respir Cell Mol Biol 10(3): 284–9CrossRef Google Scholar PubMed

Smith, T., Lehmann, D., Montgomery, J.et al. 1993. Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children. Epidemiol Infect 111(1): 27–39CrossRef Google Scholar PubMed

Soilleux, E. J., Morris, L. S., Leslie, G.et al. 2002. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J Leukoc Biol 71(3): 445–57Google Scholar PubMed

Steffen, M., Reinecker, H. C., Petersen, J.et al. 1993. Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-infected patients. Clin Exp Immunol 91(1): 30–6CrossRef Google Scholar PubMed

Stillman, E. G., and Branch, A.. 1924. Experimental production of pneumococcus pneumonia in mice by the inhalation method. J Exp Med 40: 733–42CrossRef Google Scholar PubMed

Stool, S. E. and Field, M. J.. 1989. The impact of otitis media. Pediatr Infect Dis J 8: S14CrossRef Google Scholar PubMed

Szalai, A. J. 2002. The antimicrobial activity of C-reactive protein. Microbes Infect 4: 201–5CrossRef Google Scholar PubMed

Tettelin, H., Nelson, K. E., I. T. Paulsen et al. 2001. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293: 490–505CrossRef Google Scholar PubMed

Tino, M. J., and Wright, J. R.. 1996. Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages. Am J Physiol 270: L677–88Google Scholar PubMed

Tkalcevic, J., Novelli, M., Phylactides, M.et al. 2000. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity 12: 201–10CrossRef Google Scholar PubMed

Toossi, Z., Hirsch, C. S., B. D. Hamilton et al. 1996. Decreased production of TGF-beta 1 by human alveolar macrophages compared with blood monocytes. J Immunol 156(9): 3461–8Google Scholar PubMed

Tu, A. H., Fulgham, R. L., M. A. McCrory, Briles, D. E., and Szalai, A. J.. 1999. Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae. Infect Immun 67: 4720–4Google Scholar PubMed

Tuomanen, E. I., and Masure, H. R.. 1997. Molecular and cellular biology of pneumococcal infection. Microb Drug Resist 3(4): 297–308CrossRef Google Scholar PubMed

Tuomanen, E. I., Saukkonen, K., Sande, S., Cioffe, C., and Wright, S. D.. 1989. Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J Exp Med 170: 959–69CrossRef Google Scholar PubMed

Tuomanen, E. I., Austrian, R., and Masure, H. R.. 1995. Pathogenesis of pneumococcal infection. New Engl J Med 332: 1280–4CrossRef Google Scholar PubMed

Turner, M. W., and Hamvas, R. M.. 2000. Mannose-binding lectin: structure, function, genetics and disease associations. Rev Immunogenet 2: 305–22Google Scholar PubMed

Twigg, H. L.III, Iwamoto, G. K., and Soliman, D. M.. 1992. Role of cytokines in alveolar macrophage accessory cell function in HIV-infected individuals. J Immunol 149: 1462–9Google Scholar PubMed

Underhill, D. M., and Ozinsky, A.. 2002. Phagocytosis of microbes: complexity in action. A Rev Immunol 20: 825–52CrossRef Google Scholar PubMed

Vazquez-Torres, A., J. Jones-Carson, Mastroeni, P., Ischiropoulos, H., and Fang, F. C.. 2000. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J Exp Med 192: 227–36CrossRef Google Scholar PubMed

Veenhoven, R., Bogert, D., Uiterwaal, C.et al. 2003. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on current acute otitis media: a randomised study. Lancet 361: 2189–95CrossRef Google Scholar

Venet, A., Hance, A. J., Saltini, C., Robinson, B. W., and R. G. Crystal 1985. Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis. J Clin Invest 75(1): 293–301CrossRef Google Scholar PubMed

Vermaelen, K. Y., I. Carro-Muino, Lambrecht, B. N., and Pauwels, R. A.. 2001. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J Exp Med 193(1): 51–60CrossRef Google Scholar PubMed

Wallaert, B., Aerts, C., Colombel, J. F., and Voisin, C.. 1991. Human alveolar macrophage antibacterial activity in the alcoholic lung. Am Rev Respir Dis 144(2): 278–83CrossRef Google Scholar PubMed

Walport, M. J. 2001a. Complement. First of two parts. N Engl J Med 344: 1058–66CrossRef Google Scholar

Walport, M. J. 2001b. Complement. Second of two parts. New Engl J Med 344: 1140–4CrossRef Google Scholar

Wang, Q., Teder, P., N. P. Judd, Noble, P. W., and Doerschuk, C. M.. 2002. CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice. Am J Pathol 161: 2219–28CrossRef Google Scholar PubMed

Ward, P. A. 1996. Role of complement, chemokines, and regulatory cytokines in acute lung injury. Ann N Y Acad Sci 796: 104–12CrossRef Google Scholar PubMed

Weiser, J. N., Markiewicz, Z., Tuomanen, E. I., and Wani, J. H.. 1996. Relationship between phase variation in colony morphology, intrastrain variation in cell wall physiology, and nasopharyngeal colonization by Streptococcus pneumoniae. Infect Immun 64(6): 2240–5Google Scholar PubMed

Weiser, J. N., Bae, D., Epino, H.et al. 2001. Changes in availability of oxygen accentuate differences in capsular polysaccharide expression by phenotypic variants and clinical isolates of Streptococcus pneumoniae. Infect Immun 69(9): 5430–9CrossRef Google Scholar PubMed

Weiser, J. N., Bae, D., Fasching, C., R. W. Scamurra, Ratner, A. J., and Janoff, E. N.. 2003. Antibody-enhanced pneumococcal adherence requires IgA1 protease. Proc Natl Acad Sci USA 100: 4215–20CrossRef Google Scholar PubMed

Wewers, M. D., Rennard, S. I., A. J. Hance, Bitterman, P. B., and Crystal, R. G.. 1984. Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1. J Clin Invest 74(6): 2208–18CrossRef Google Scholar PubMed

Whitney, C. G., Farley, M. M., Hadler, J.et al. 2003. Decline in invasive pneumococcal disease after introduction of protein-polysaccharide conjugate vaccine. New Engl J Med 348: 1737–46CrossRef Google Scholar PubMed

Williams, B. G., Gouws, E., C. Boschi-Pinto, Bryce, J., and Dye, C.. 2002. Estimates of worldwide distribution of child deaths from acute respiratory infections. Lancet Infect Dis 2: 25–32CrossRef Google Scholar PubMed

Xu, Y., Ma, M., G. C. Ippolito et al. 2001. Complement activation in factor D-deficient mice. Proc Natl Acad Sci USA 98: 14577–82CrossRef Google Scholar PubMed

Yesilkaya, H., Kadioglu, A., Gingles, N.et al. 2000. Role of manganese-containing superoxide dismutase in oxidative stress and virulence of Streptococcus pneumoniae. Infect Immun 68: 2819–26CrossRef Google Scholar PubMed

Yrlid, U., and Wick, M. J.. 2000. Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells. J Exp Med 191: 613–24CrossRef Google Scholar PubMed

Zamze, S., L. Martinez-Pomares, H. Jones et al. 2002. Recognition of bacterial capsular polysaccharides and lipopolysaccharides by the macrophage mannose receptor. J Biol Chem 277(44): 41613–23CrossRef Google Scholar PubMed

Zandvoort, A., and Timens, W.. 2002. The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens. Clin Exp Immunol 130(1): 4–11CrossRef Google Scholar PubMed

Zhang, Y., Suankratay, C., X. H. Zhang et al. 1999. Calcium-independent haemolysis via the lectin pathway of complement activation in the guinea-pig and other species. Immunology 97: 686–92CrossRef Google Scholar PubMed

Zuercher, A. W., Jiang, H. Q., M. C. Thurnheer, Cuff, C. F., and Cebra, J. J.. 2002. Distinct mechanisms for cross-protection of the upper versus lower respiratory tract through intestinal priming. J Immunol 169(7): 3920–5CrossRef Google Scholar PubMed

Zychlinsky, A., and Sansonetti, P.. 1997. Perspectives series: host/pathogen interactions. Apoptosis in bacterial pathogenesis. J Clin Invest 100: 493–5CrossRef Google Scholar PubMed

Zysk, G., Bejo, L., B. K. Schneider-Wald, Nau, R., and Heinz, H.. 2000. Induction of necrosis and apoptosis of neutrophil granulocytes by Streptococcus pneumoniae. Clin Exp Immunol 122: 61–6CrossRef Google Scholar PubMed

Book contents

5 - Phagocytosis of Streptococcus pneumoniae

Summary

Access options

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive